IL-12 targeting could open pathways for new Alzheimer’s treatments
Researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer's disease. The study was…
Read More...
Read More...